AnaptysBio at UBS Global Biopharma Conference 2026: Royalty growth, legal risk
AI Summary
AnaptysBio discussed royalty growth and legal risks at the UBS Global Biopharma Conference 2026. The headline signals investor-relevant developments but provides no details about the royalties or legal issues.